In the BRCA1/2 mutation group, there were 4 cases (14.8%) whose immediate family members were tumor patients, including colorectal cancer, ovarian cancer, esophageal cancer, and breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.